Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Game theory explains why reasonable parents make vaccine choices that fuel outbreaks - 2The Significance of a Land Lawyer for Your Business
- 3Bronze Age "City of Seven Ravines" unearthed in central Asia after 3,500 years
- 4Why home maintenance deserves a spot in the annual health and budget plans
- 5The 10 Most Persuasive Forerunners in Innovation
- NASA counts down for first crewed lunar mission in half a century
- Figure out How to Use the Experience of a Fender bender Legal counselor for Your Potential benefit
- Norovirus is spreading earlier again this year, wastewater data shows
- The Best 20 Tunes that Characterized an Age
- The most effective method to Pick the Ideal Shrewd Bed for Your Special Rest Needs
- Step by step instructions to Shield Your Wellbeing Around 5G Pinnacles\
- Arctic sea ice hits lowest winter level as unprecedented heat hits smashes records all over Earth
- Manual for Picking the Ideal Wine Matching
- Fuel Price Spike Drives Surge in Used EV Sales in Europe
